HomeFile

File

Deferring Lesions by FFR in ACS: Yes or No?

Deferring treatment through angioplasty in non-ischemic lesions by fractional flow reserve (FFR) is associated with excellent long-term...

Stroke Predictors in TAVR: CoreValve vs. Sapien

A comprehensive analyzis of cerebrovascular events in major randomized controlled studies on transcatheter aortic valve replacement (TAVR)...

Paravalvular Insufficiency After TAVR: A Better Predictor of Endocarditis

Data from this large international registry associate endocarditis after a transcatheter aortic valve replacement (TAVR) with high...

New TAVR Devices: Better Results in Bicuspids

Courtesy of del Dr. Carlos Fava.   The bicuspid aortic valve is highly anatomically challenging because of valve asymmetric...

Culotte vs. TAP in Bifurcations: Which is Better?

Courtesy of Dr. Agustín Vecchia.   In treating bifurcations, the provisional stenting strategy continues to be preferred. However, a...

Dual Antiplatelet Therapy in Men and Women: Are There Differences?

Courtesy of Dr. Agustín Vecchia.   Currently, the duration of dual antiplatelet therapy (DAPT) after stent placement is one of the...

Contrast Induced FFR: Cost and Time Effective Alternative

Courtesy of Dr. Guillermo Migliaro.   Fractional flow reserve (FFR) is the radio of two flows expressed as the...

Xience V: Safe in “Real-Life” Bifurcation Lesions

Courtesy of Dr. Rodrigo Abreu.   INTRODUCTION Bifurcation lesion treatment has evolved considerably in the last years: from balloon angioplasty...